Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral‐host interaction with implications for disease intervention
Maísa Pinheiro, Julia C. Gage, Gary M. Clifford, et al.
International Journal of Cancer (2020) Vol. 147, Iss. 10, pp. 2677-2686
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
Maria Demarco, Noorie Hyun, Olivia Carter‐Pokras, et al.
EClinicalMedicine (2020) Vol. 22, pp. 100293-100293
Open Access | Times Cited: 165
Cervical cancer prevention and control in women living with human immunodeficiency virus
Philip E. Castle, Mark H. Einstein, Vikrant V. Sahasrabuddhe
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 6, pp. 505-526
Open Access | Times Cited: 146
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
Laia Bruni, G. Albero, Jane Rowley, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 9, pp. e1345-e1362
Open Access | Times Cited: 123
Human papillomavirus genomics: Understanding carcinogenicity
Chase W. Nelson, Lisa Mirabello
Tumour Virus Research (2023) Vol. 15, pp. 200258-200258
Open Access | Times Cited: 56
The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing
Kanan Desai, Brian Befano, Zhiyun Xue, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 5, pp. 741-752
Open Access | Times Cited: 59
Single dose HPV vaccine in achieving global cervical cancer elimination
Victoire Fokom-Defo, Issimouha Dille, Joël Fokom Domgue
The Lancet Global Health (2024) Vol. 12, Iss. 3, pp. e360-e361
Open Access | Times Cited: 9
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines
L. Stewart Massad, Megan A. Clarke, Rebecca B. Perkins, et al.
Journal of Lower Genital Tract Disease (2025)
Closed Access | Times Cited: 1
A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer
Nicole G. Campos, Maria Demarco, Laia Bruni, et al.
Preventive Medicine (2021) Vol. 144, pp. 106438-106438
Open Access | Times Cited: 33
High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention
Zizipho Z. A. Mbulawa, Keletso Phohlo, Mirta Garcia-Jardon, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0264498-e0264498
Open Access | Times Cited: 24
Genetic variations and carcinogenicity analysis of E6/E7 oncogenes in HPV31 and HPV35 in Taizhou, China
Haobo Yuan, Junhui Yu, Jun Gan, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
The Burden of HPV Infections and HPV‐Related Diseases Among People With HIV: A Systematic Literature Review
Bekana K. Tadese, Xuedan You, Tidiane Ndao, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Open Access
Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
Megan A. Clarke, Carolann Risley, Mary W. Stewart, et al.
Cancer Medicine (2021) Vol. 10, Iss. 23, pp. 8641-8650
Open Access | Times Cited: 27
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management
Jacqueline Mix, Mona Saraiya, Benjamin D. Hallowell, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 114, Iss. 6, pp. 845-853
Open Access | Times Cited: 21
High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV
Wenkosi Perez Qulu, Andile Mtshali, Farzana Osman, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294698-e0294698
Open Access | Times Cited: 11
Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing
Kayode Olusegun Ajenifuja, Jerome L. Belinson, Andrew Goldstein, et al.
Infectious Agents and Cancer (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 30
APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma
Daniel L. Faden, Krystle A. Lang Kuhs, Maoxuan Lin, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1666-1666
Open Access | Times Cited: 26
High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa
Zizipho Z. A. Mbulawa, Nontuthuzelo Somdyala, Sikhumbuzo A. Mabunda, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253074-e0253074
Open Access | Times Cited: 25
An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series
Johnny Yang, Mary R Nittala, Alexander E Velazquez, et al.
Cureus (2023)
Open Access | Times Cited: 10
Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing
Kathryn A. Kundrod, José Jerónimo, Beatrice Vetter, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 8, pp. e0001982-e0001982
Open Access | Times Cited: 9
Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control
Philip E. Castle
Viruses (2024) Vol. 16, Iss. 9, pp. 1357-1357
Open Access | Times Cited: 3
Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women
Lauren G. Johnson, Rakiya Saidu, Zizipho Z. A. Mbulawa, et al.
Cancer Medicine (2020) Vol. 9, Iss. 18, pp. 6813-6824
Open Access | Times Cited: 26
Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa
Ongeziwe Taku, Zizipho Z. A. Mbulawa, Keletso Phohlo, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 280-280
Open Access | Times Cited: 22
High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women
Oppah Kuguyo, Racheal S. Dube Mandishora, Nicholas Ekow Thomford, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257324-e0257324
Open Access | Times Cited: 21
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
Brandon Chua, Li Min Lim, Joseph Ng, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1812-1812
Open Access | Times Cited: 8
Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial
Mark H. Stoler, Thomas C. Wright, Valentin Parvu, et al.
Gynecologic Oncology (2023) Vol. 170, pp. 143-152
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top